ESQLABS
LIVE

Serial Number

79421787

Owner

esqlabs GmbH

Attorney

Kristen H. Mowery

Filing Date

Nov 27, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ESQLABS Trademark

Serial Number: 79421787 • Registration: 8248555

ESQLABS is a trademark filed by esqlabs GmbH on November 27, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

esqlabs GmbH

Am Sportplatz 7

Entity Type: 98

Trademark Details

Filing Date

November 27, 2024

Registration Date

May 12, 2026

Published for Opposition

March 24, 2026

Goods & Services

Blank digital storage media; Electronic publications, namely training manuals in electronic form; downloadable computer software and software platforms for modelling and simulation, in particular in the field of pharmacy, chemistry or plant protection; downloadable modelling and simulation computer software and platforms for physiologically-based pharmacokinetics (PBPK) and quantitative systems pharmacology (QSP); downloadable computer software and software platforms for investigating organ damage; downloadable computer software and software platforms for investigating drug-drug interactions (DDI); downloadable computer software and software platforms for translational modelling for human initial dose prediction; downloadable computer software and software platforms for developing, calculating and analysing mathematical models and simulations, in particular in the field of life sciences; downloadable graphical user interface software being software and software platforms with graphical user interfaces for various operating systems and platforms; downloadable computer software and software platforms for solving numerical problems; downloadable computer software and software platforms for analysing data, in particular statistically; downloadable computer software and software platforms for graphical visualisation of simulation results and observed data; downloadable computer software packages for programming languages in the nature of downloadable software development kits (SDK); electronic databases in the field of pharmacy, chemistry or plant protection recorded on computer media

IT consulting services relating to installation, maintenance and repair of computer software; software as a service (SaaS) featuring software for modelling and simulation in the field of pharmacy, chemistry and plant protection; platform as a service (PaaS) featuring computer software platforms for modelling and simulation in the field of pharmacy, chemistry or plant protection; computer services for data analyses, namely, computerized analysis and interpretation of data concerning pharmacy, chemistry, and plant protection; conducting of technical data analyses in the field of pharmacy, chemistry or plant protection; design, development, programming and implementation of software and software platforms for modelling and simulation, in particular in the field of pharmacy, chemistry or plant protection; design, development, programming and implementation of physiologically-based pharmacokinetics (PBPK) and quantitative systems pharmacology (QSP) modelling and simulation software and platforms; design, development, programming and implementation of software and software platforms for the development of preclinical or clinical physiologically-based pharmacokinetics (PBPK) software models; design, development, programming and implementation of software and software platforms for investigating organ damage; design, development, programming and implementation of software and software platforms for investigating drug-drug interactions (DDI); design, development, programming and implementation of software and software platforms for translational modelling for human initial dose prediction; design, development, programming and implementation of software and software platforms for the development, calculation and analysis of mathematical models and simulations, in particular in the field of life sciences; design, development, programming and implementation of software and software platforms with graphical user interfaces for various operating systems and platforms; design, development, programming and implementation of software and software platforms for solving numerical problems; design, development, programming and implementation of software and software platforms for statistical analysis of data; design, development, programming and implementation of software and software platforms for the graphical visualisation of simulation results and observed data; design, development, programming and implementation of packages for programming languages being software development kits (SDK); design, development, programming and implementation of electronic databases recorded on computer media; provision of temporary use of online non-downloadable software and software platforms for modelling and simulation, in particular in the field of pharmacy, chemistry or plant protection; provision of temporary use of online non-downloadable physiologically-based pharmacokinetics (PBPK) and quantitative systems pharmacology (QSP) modelling and simulation software and platforms, in particular in the field of pharmacy, chemistry or plant protection; provision of temporary use of online non-downloadable software and software platforms for the development of preclinical or clinical physiologically-based pharmacokinetics (PBPK) software models; provision of temporary use of online non-downloadable software and software platforms for the investigation of organ damage; provision of temporary use of online non-downloadable software and software platforms for investigating drug-drug interactions (DDI); provision of temporary use of online non-downloadable software and software platforms for translational modelling for human initial dose prediction; provision of temporary use of online non-downloadable software and software platforms for the development, calculation and analysis of mathematical models and simulations, in particular in the field of life sciences; provision of temporary use of online non-downloadable graphical user interface software being software and software platforms for various operating systems and platforms; provision of temporary use of online non-downloadable software and software platforms for solving numerical problems; provision of temporary use of online non-downloadable software and software platforms for analysing data, in particular statistically; provision of temporary use of online non-downloadable software and software platforms for graphical visualisation of simulation results and observed data; technological and scientific consulting services in the field of pharmacy, chemistry or plant protection; IT consultancy, advisory and information services related to installation, maintenance and repair of computer software; IT consultancy, advisory and information services relating to software and software platforms for modelling and simulation, in particular in the field of pharmacy, chemistry or plant protection; IT consultancy, advisory and information services relating to physiologically-based pharmacokinetics (PBPK) and quantitative systems pharmacology (QSP) modelling and simulation software and platforms, in particular in the field of pharmacy, chemistry or plant protection; IT consultancy, advisory and information services relating to installation, maintenance and repair of computer software and software platforms for the development of preclinical or clinical physiologically-based pharmacokinetics (PBPK) software models; IT consultancy, advisory and information services relating to installation, maintenance and repair of computer software and software platforms for studying organ damage; IT consultancy, advisory and information services relating to installation, maintenance and repair of computer software and software platforms for investigating drug-drug interactions (DDI); IT consultancy, advisory and information services relating to installation, maintenance and repair of computer software and software platforms for translational modelling for human initial dose prediction; IT consultancy, advisory and information services relating to installation, maintenance and repair of computer software and software platforms for the development, calculation and analysis of mathematical models and simulations, in particular in the field of life sciences; IT consultancy, advisory and information services relating to installation, maintenance and repair of graphical user interface computer software and software platforms for various operating systems and platforms; IT consultancy, advisory and information services relating to installation, maintenance and repair of computer software and software platforms for solving numerical problems; IT consultancy, advisory and information services relating to installation, maintenance and repair of computer software and software platforms for analysing data, in particular statistically; IT consultancy, advisory and information services relating to installation, maintenance and repair of computer software and software platforms for the graphical visualisation of simulation results and observed data; IT consultancy, advisory and information services relating to the development and implementation of packages for programming languages being software development kits (SDK); IT consultancy, advisory and information services relating to the creation and integration of electronic databases; installation, setting up and maintenance of software; installation, setting up and maintenance of software and software platforms for modelling and simulation, in particular in the field of pharmacy, chemistry or plant protection; installation, setting up and maintenance of physiologically-based pharmacokinetics (PBPK) and quantitative systems pharmacology (QSP) modelling and simulation software and platforms; installation, setting up and maintenance of software and software platforms for the development of preclinical or clinical physiologically-based pharmacokinetics (PBPK) software models; installation, setting up and maintenance of software and software platforms for investigating organ damage; installing, setting up and maintenance of software and software platforms for investigating drug-drug interactions (DDI); installation, setting up and maintenance of software and software platforms for translational modelling for human initial dose prediction; installing, setting up and maintenance of software and software platforms for developing, calculating and analysing mathematical models and simulations, in particular in the field of life sciences; installing, setting up and maintenance of software and software platforms with graphical user interfaces for various operating systems and platforms; installing, setting up and maintenance of software and software platforms for solving numerical problems; installing, setting up and maintenance of software and software platforms for analysing data, in particular statistically; installing, setting up and maintenance of software and software platforms for the graphical visualisation of simulation results and observed data; installation, setting up and maintenance of packages for programming languages being software development kits (SDK); installation, setting up and maintenance of electronic databases; medical and pharmaceutical research services

Education, training and teaching, namely, teaching, training, tutoring and courses of instruction at the undergraduate, graduate and post-graduate level; training and education services being instruction in the field of pharmacy, chemistry or plant protection; organisation and provision of training courses in the field of pharmacy, chemistry and plant protection; organisation and provision of training courses, conferences, workshops and seminars relating to software and software platforms for modelling and simulation, in particular in the fields of pharmacy, chemistry and plant protection; organisation and provision of training courses, conferences, workshops and seminars relating to physiologically-based pharmacokinetics (PBPK) and quantitative systems pharmacology (QSP) modelling and simulation software and platforms; organisation and provision of training courses, conferences, workshops and seminars relating to the development of preclinical or clinical physiologically-based pharmacokinetics (PBPK) software models; organisation and provision of training courses, conferences, workshops and seminars relating to software and software platforms for investigating organ damage; organisation and provision of training courses, conferences, workshops and seminars relating to software and software platforms for investigating drug-drug interactions (DDI); organisation and provision of training courses, conferences, workshops and seminars relating to software and software platforms for translational modelling for initial dose prediction in humans; organisation and provision of training courses, conferences, workshops and seminars relating to software and software platforms for the development, calculation and analysis of mathematical models and simulations, in particular in the field of life sciences; organisation and provision of training courses, conferences, workshops and seminars relating to graphical user interface software and software platforms for various operating systems and platforms; organisation and provision of training courses, conferences, workshops and seminars relating to software and software platforms for solving numerical problems; organisation and provision of training courses, conferences, workshops and seminars relating to software and software platforms for the statistical evaluation of data; organisation and provision of training courses, conferences, workshops and seminars relating to software and software platforms for the graphical representation of simulation results and observed data; organisation and provision of training courses, conferences, workshops and seminars relating to the development and implementation of packages for programming languages being software development kits (SDK); organisation and provision of training courses, conferences, workshops and seminars relating to the creation and integration of electronic databases; creation of training materials in the field of pharmacy, chemistry, and plant protection both in hard copy and electronic forms including books, videos, and software; creation of training materials, both in hard copy and electronic forms including books, videos, and software, relating to software and software platforms for modelling and simulation, in particular in the fields of pharmacy, chemistry and plant protection; creation of training materials, both in hard copy and electronic forms including books, videos, and software, relating to physiologically-based pharmacokinetics (PBPK) and quantitative systems pharmacology (QSP) modelling and simulation software and platforms; creation of training materials, both in hard copy and electronic forms including books, videos, and software, relating to the development of preclinical or clinical physiologically-based pharmacokinetics (PBPK) software models; creation of training materials, both in hard copy and electronic forms including books, videos, and software, relating to software and software platforms for studying organ damage; creation of training materials, both in hard copy and electronic forms including books, videos, and software, relating to software and software platforms for the study of drug-drug interactions (DDI); creation of training materials, both in hard copy and electronic forms including books, videos, and software, relating to software and software platforms for translational modelling for human initial dose prediction; creation of training materials, both in hard copy and electronic forms including books, videos, and software, relating to software and software platforms for developing, calculating and analysing mathematical models and simulations, in particular in the field of life sciences; creation of training materials, both in hard copy and electronic forms including books, videos, and software, relating to graphical user interface software and software platforms for different operating systems and platforms; creation of training materials, both in hard copy and electronic forms including books, videos, and software, relating to software and software platforms for solving numerical problems; creation of training materials, both in hard copy and electronic forms including books, videos, and software, relating to software and software platforms for statistical analysis of data; creation of training materials, both in hard copy and electronic forms including books, videos, and software, relating to software and software platforms for the graphical visualisation of simulation results and observed data; creation of training materials, both in hard copy and electronic forms including books, videos, and software, relating to the development and implementation of packages for programming languages, being software development kits (SDK); creation of training materials, both in hard copy and electronic forms including books, videos, and software, relating to the creation and integration of electronic databases

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 12, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 12, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 24, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 24, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 18, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 26, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 26, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 26, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 26, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 26, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 23, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 23, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 23, 2026 TROA
REFUSAL PROCESSED BY IB
Aug 8, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 24, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jul 24, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 30, 2025 RFCR
NON-FINAL ACTION WRITTEN
May 29, 2025 CNRT
ASSIGNED TO EXAMINER
May 19, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 25, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 25, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 17, 2025 REPR